Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apitoxin vs LLLT for Aphthous Ulceration
NCT07135609Completed
- Sponsor
- Tanta University
- Start
- Apr 2024
- Primary completion
- Feb 2025
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of apis mellifera venom in recurrent aphthous stomatitis (RAS) (2 arms), sponsored by Tanta University. Primary endpoint: Ulcer Surface Area. Started Apr 2024; status: completed.
02
Drugs
apis mellifera venom
03
Conditions
recurrent aphthous stomatitis (RAS)
Beyond the preview
Go deeper on NCT07135609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07135609.